Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: A retrospective study
Autore:
Coleman, E; Gratzer, T; Nesvacil, L; Raymond, NC;
Indirizzi:
Univ Minnesota, Sch Med, Dept Family Practice & Community Hlth, Program Human Sexual, Minneapolis, MN 55454 USA Univ Minnesota Minneapolis MN USA 55454 Sexual, Minneapolis, MN 55454 USA Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55454 USA Univ Minnesota Minneapolis MN USA 55454 ychiat, Minneapolis, MN 55454 USA
Titolo Testata:
JOURNAL OF CLINICAL PSYCHIATRY
fascicolo: 4, volume: 61, anno: 2000,
pagine: 282 - 284
SICI:
0160-6689(200004)61:4<282:NATTON>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
PARAPHILIAS; ADDICTIONS; MEN;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Citazioni:
14
Recensione:
Indirizzi per estratti:
Indirizzo: Coleman, E Univ Minnesota, Sch Med, Dept Family Practice & Community Hlth,Program Human Sexual, 1300 S 2nd St,Suite 180, Minneapolis, MN 55454 USA Univ Minnesota 1300 S 2nd St,Suite 180 Minneapolis MN USA 55454
Citazione:
E. Coleman et al., "Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: A retrospective study", J CLIN PSY, 61(4), 2000, pp. 282-284

Abstract

Background: Recent reports suggest that individuals with nonparaphilic compulsive sexual behavior can be treated pharmacologically with selective serotonin reuptake inhibitors (SSRIs) to control sexual obsessions and compulsions. However, these medications have produced sexual side effects that maylimit long-term use, particularly as individuals strive to reestablish healthy sexual relationships. Nefazodone is an antidepressant that is not associated with the sexual side effects of other SSRIs. We examined retrospective data from our clinic to investigate whether nefazodone has utility in the treatment of nonparaphilic compulsive sexual behavior. Method: Fourteen subjects who met DSM-IV criteria for sexual disorder NOS as well as criteria used by our research group for nonparaphilic compulsivesexual behavior and who had been treated with nefazodone were selected from patient charts at our clinic. The treating physician abstracted information from the charts regarding comorbid psychiatric conditions, medication, dosage, treatment response, and side effects. Results: In this study, the mean dosage of nefazodone was 200 mg/day. Of the subjects who remained on long-term nefazodone therapy, 6 (55%) reported good control of sexual obsessions and compulsions, and 5 (45%) reported a remission of sexual obsessions and compulsions. Conclusion: Results from this preliminary retrospective study suggest thatnefazodone decreases the frequency of sexual obsessions and compulsions but does not produce the undesired sexual side effects caused by SSRI treatment.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 06:03:50